Enoxaparin sodium [679809-58-6]
Referentie T22323-2mg
Formaat : 2mg
Merk : TargetMol
Neem contact op met een lokale distributeur :
Telefoonnummer : +1 850 650 7790
Enoxaparin sodium
Enoxaparin sodium
Contact us for more batch information
Potency:90-125 IU/mg (Anti-Xa based on dry weight)
Resource Download
COA
Enoxaparin sodium
Catalog No. T22323Cas No. 679809-58-6
Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI). It binds to and potentiates the action of antithrombin, and inhibits coagulation factors XIa, IXa, Xa and IIa (thrombin), thereby preventing formation of blood clots.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose. | Pack Size | |
|---|---|
| 1 mg | |
| 2 mg | |
| 5 mg | |
| 10 mg | |
| 25 mg | |
| 50 mg | |
| 100 mg | |
| 200 mg |
Product Introduction
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Enoxaparin sodium is a low-molecular-weight heparin (LMWH) that has recently been approved by the US FDA for use in patients with medically managed ST-segment myocardial infarction (STEMI), or STEMI with subsequent percutaneous coronary intervention (PCI) |
| Molecular Weight | 1322 |
| Formula | C42H59N3Na4O35S2 |
| Cas No. | 679809-58-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility Information | DMSO: Insoluble |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg,each 
animal weighs 20 g, and the dosage volume is 100 μL. A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL.
Mother liquor preparation method: 2 mg of drug dissolved in 50 μLDMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μLDMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μLTween 80, mix well and clarify, then add 600 more μLddH2O mix well and clarify.
Dose Conversion
You can also refer to dose conversion for different animals. More
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Keywords
traumatic brain injuryinfectioncoronavirusEnoxaparin sodiumInhibitorPK-10169ThrombininhibitSARS-CoVEnoxaparinneuroprotectiveLiver fibrosisFxaPK 10169InflammationPK10169SARS coronavirusacute coronary syndromesFactor XaLovenoxblood clotsCOVID-19Thioacetamide